- Home
- IMMX vs ASRV Comparison
IMMX vs ASRV Comparison
Compare IMMX & ASRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMX
- ASRV
- Stock Information
- Founded
- IMMX 2014
- ASRV 1983
- Country
- IMMX United States
- ASRV United States
- Employees
- IMMX 21
- ASRV N/A
- Industry
- IMMX Medicinal Chemicals and Botanical Products
- ASRV Major Banks
- Sector
- IMMX Health Care
- ASRV Finance
- Exchange
- IMMX Nasdaq
- ASRV Nasdaq
- Market Cap
- IMMX 54.9M
- ASRV 40.1M
- IPO Year
- IMMX 2021
- ASRV N/A
- Fundamental
- Price
- IMMX $2.34
- ASRV $2.81
- Analyst Decision
- IMMX Strong Buy
- ASRV
- Analyst Count
- IMMX 1
- ASRV 0
- Target Price
- IMMX $7.00
- ASRV N/A
- AVG Volume (30 Days)
- IMMX 360.1K
- ASRV 21.7K
- Earning Date
- IMMX 06-10-2025
- ASRV 07-15-2025
- Dividend Yield
- IMMX N/A
- ASRV 4.30%
- EPS Growth
- IMMX N/A
- ASRV N/A
- EPS
- IMMX N/A
- ASRV 0.22
- Revenue
- IMMX N/A
- ASRV $53,037,000.00
- Revenue This Year
- IMMX N/A
- ASRV N/A
- Revenue Next Year
- IMMX N/A
- ASRV N/A
- P/E Ratio
- IMMX N/A
- ASRV $12.97
- Revenue Growth
- IMMX N/A
- ASRV 16.87
- 52 Week Low
- IMMX $1.26
- ASRV $2.03
- 52 Week High
- IMMX $2.71
- ASRV $3.06
- Technical
- Relative Strength Index (RSI)
- IMMX 61.49
- ASRV 79.00
- Support Level
- IMMX $1.89
- ASRV $2.64
- Resistance Level
- IMMX $2.50
- ASRV $2.67
- Average True Range (ATR)
- IMMX 0.17
- ASRV 0.10
- MACD
- IMMX 0.00
- ASRV 0.03
- Stochastic Oscillator
- IMMX 73.77
- ASRV 97.46
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About ASRV AmeriServ Financial Inc.
AmeriServ Financial Inc is a bank holding company. The company and its subsidiaries derive substantially all of their income from banking, bank-related services, and trust-related services. Its operating segment includes community banking and it generates maximum revenue. The community banking segment includes both retail and commercial banking activities. The company also offers retail banking which includes the deposit-gathering branch franchise and lending to both individuals and small businesses; Lending activities include residential mortgage loans, direct consumer loans, and small business commercial loans; Commercial banking to businesses includes commercial loans, business services, and CRE loans.